Given that MerTK is highly expressed in about one-third of human TNBCs and MerTK overexpression is linked to tumor progression in vitro, we hypothesized that tumors overexpressing MerTK would grow faster in vivo and lead to an immunosuppressive TIME. Here, MERTK is linked to neoplasm.